… the hemodynamic, neurohumoral, and biochemical effects of the novel angiotensin type 1
(AT 1 ) receptor antagonist irbesartan in 86 untreated patients with essential hypertension on a …

… , in essential hypertension, once-daily irbesartan effectively lowers blood pressure. This …
evaluation of the hemodynamic, neurohumoral, and biochemical effects of three different doses (…

… have been proposed as new drugs for portal hypertension. This randomized, placebo-…
effect of the angiotensin II receptor antagonist irbesartan on portal and systemic hemodynamics …

… Hemodynamic and biochemical effects of the AT 1 receptor antagonist irbesartan in
hypertension… Effect of the AT1-receptor antagonist irbesartan on plasma angiotensinogen …

… study, once-daily doses of irbesartan or atenolol effectively lowered blood pressure, but …
Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension…

… with Irbesartan 300 mg orally once daily for 60 days. Hemodynamic evaluations and biochemical
tests … on portal hypertension and its impact on systemic hemodynamic in liver cirrhosis. …

… Irbesartan has characteristics similar to other ARBs, but it blocks … Furthermore, it has
beneficial renal hemodynamic effects such as increase in renal blood flow, maintenance of or an …

… effect occurred at 4 hours. Conclusions: Irbesartan increases plasma AII and PRA and
lowers BP consistent with AT1 receptor blockade, without clinically important effects on renal …

… —such as intrinsic vascular modifications, hemodynamic changes… its target receptors to
produce a biological signal conducted … Irbesartan has similar characteristics to other antagonists, …

… than AT 1 receptor antagonists at reducing blood pressure in spontaneously hypertensive
… compound A with the imidazolinone of irbesartan, we were able to add potent AT 1 receptor …